Evidence map›Paper›PMID 22405323›Full record

ArticleRetrovirology2012

New and novel intrinsic host repressive factors against HIV-1: PAF1 complex, HERC5 and others.

Mudit Tyagi, Fatah Kashanchi

Abstract readEditorialComment
In one paragraph

Article in Retrovirology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Insights into the HIV Latency and the Role of Cytokines.Pathogens (Basel, Switzerland) · 2019
    Review
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Mudit TyagiNational Center for Biodefense and Infectious Diseases, George Mason University, Discovery Hall, Room 182, University Blvd, MS 1H8, 10900 Manassas, VA, USA.
Fatah Kashanchi

Funding

HIV1 INHIBITION USING TAT PEPTIDE DERIVATIVESR01AI043894 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI KASHANCHI, FATAH · 1999 to 2015
$4.4M
Effect of chromatin remodelers/modifiers on HIV-1 Tat activated transcriptionR21AI074410 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI KASHANCHI, FATAH · 2009 to 2010
$432k
HIV-1 TAR derived miRNA: Implications for Latency and PathogenesisR21AI078859 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI KASHANCHI, FATAH · 2009 to 2010
$400k
Medical Research Council G117/547NIAID NIH HHS AI043894NIAID NIH HHS AI074410NIAID NIH HHS AI078859NIAID NIH HHS R01 AI043894
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genome, HumanVirus AssemblyVirus ReplicationGene Products, gagHIVHIV-1HIV InfectionsHumansIntracellular Signaling Peptides and ProteinsProteinsGene Products, gagIntracellular Signaling Peptides and ProteinsProteins

Identifiers

PMID22405323
PMCPMC3311033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.